57
Views
0
CrossRef citations to date
0
Altmetric
Clinical Note

Seasonal facial erythema in a patient with allergic rhinitis treated using a combination of tranilast and roxithromycin

ORCID Icon
Pages 508-510 | Received 14 Jun 2022, Accepted 19 Nov 2022, Published online: 15 Dec 2022

References

  • Meng Y, Wang C, Zhang L. Advances and novel developments in allergic rhinitis. Allergy. 2020;75(12):3069–3076.
  • Osada T, Okano M. Japanese cedar and cypress pollinosis updated: new allergens, cross-reactivity, and treatment. Allergol Int. 2021;70(3):281–290.
  • Pawankar R, Yamagishi S, Yagi T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol. 2000;14(5):309–317.
  • Yokozeki H, Satoh T, Katayama I, et al. Airborne contact dermatitis due to japanese cedar pollen. Contact Dermatitis. 2007;56(4):224–228.
  • Krouse JH. Allergic rhinitis–current pharmacotherapy. Otolaryngol Clin North Am. 2008;41(2):347–358.
  • Durham SR, Penagos M. Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol. 2016;137(2):339–349.e10.
  • Horiuchi Y. Intractable prurigo nodularis: synergistic effects of tranilast and roxithromycin. Skinmed. 2022;20:476–477.
  • Cury Martins J, Martins C, Aoki V, et al. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015;2015(7):CD009864.
  • Gonzales-de-Olano D, Alvarez-Twose I. Mast cells as key players in allergy and inflammation. J Investig Allergol Clin Immunol. 2018;28(6):365–378.
  • Fokkens WJ, Godthelp T, Holm AF, et al. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study. Clin Exp Allergy. 1992;22(7):701–710.
  • Darakhshan S, Pour AB. Tranilast: a review of its therapeutic applications. Pharmacol Res. 2015;91:15–28.
  • Kobayashi M, Shimauchi T, Hino R, et al. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell Immunol. 2004;228(1):27–33.
  • Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol. 2015;27(1):11–20.
  • Puviani M, Agostinis F, Milani M. Barrier repair therapy for facial atopic eczema with a non-steroidal emollient cream containing rhamnosoft, ceramides and iso-leucine. A six-case report series. Minerva Pediatr. 2014;66(4):307–311.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.